Why are we not seeing blockbuster drugs in the market nowadays from the Pharma industry?
High R&D Spend20%
Stricter Regulations56%
Barriers to enter the established Pharma market15%
There is no such term called blockbuster drugs7%
328 PARTICIPANTS
Director of Engineering in Media, 10,001+ employees
All the factors but predominantly the R&D factor significance cannot be ignored.VP of Marketing & Solutions — Artificial Intelligence in Software, 10,001+ employees
Didn’t we see several being developed and distributed (with emergency approval) within the first year of the pandemic? (Irrespective of one’s personal choice to use them or not.)Content you might like
Funding will dry for non profitable startups31%
No scarcity of funding in market57%
Recession will not hit6%
Funding will continue in high valuations6%
133 PARTICIPANTS
Yes, it has been a big part of our revenue for the past 2+ years.16%
Yes, we implemented a D2C strategy in the last year.52%
No, but we are planning to go direct-to-consumer in the coming year.17%
No, that isn't a business model that would work for us.9%
It is in the plans but we haven't prioritized it.2%
Unsure.2%
312 PARTICIPANTS